AssetMax.ai

About Us

ABOUT US

Built by operators who think like investors.

AssetMax.ai was founded by Davide Boiardi and Steve Denby to provide private equity funds, family offices, sell-side advisors, corporate M&A teams, and portfolio companies with decision-grade intelligence and execution support across the deal lifecycle.

We support investors end-to-end—from sourcing and underwriting to execution and exit—combining deep technology, diligence, and AI capability with hands-on value creation. The result: higher conviction pre-deal, measurable EBITDA impact during the holding period, and buyer-ready evidence at exit.

AssetMax is building an IP-led intelligence platform with proprietary tools and codified delivery that scales beyond individuals and stands up to buyer scrutiny.

Repeatable outputs. Measurable outcomes. Premium valuations.

 

Deep expertise

Operators across the full deal lifecycle.

We support private equity funds, portfolio companies, and sell-side advisors from origination and diligence through value creation and exit—bringing execution depth, not just advice.

Focus

IP-led. Repeatable. Scalable.

We deliver through codified playbooks and integrated platform capabilities—reducing key-person dependency and enabling consistent execution across entire portfolios.

Strategic ambition

Built for premium outcomes.

We are building an intelligence platform designed to drive premium exit multiples—applying the same rigor, discipline, and value-creation mindset we bring to our clients.

Diligize is now part of AssetMax

Technology due diligence is now delivered within the AssetMax intelligence platform for investors.

From Specialist Capability to Intelligence Platform

Diligize’s technology diligence capability now operates within AssetMax — a platform built to support investors across the full deal lifecycle.

AssetMax combines market intelligence, deal sourcing, due diligence, value creation, and exit readiness into a single intelligence platform designed for private equity and strategic investors. Diligize remains a core capability within the AssetMax platform.

Diligize technology due diligence services are now delivered as part of the AssetMax platform.

Managing Partner

Tech diligence and value creation specialist for private equity. Former founder and operator delivering clear insights, quantified risk, and execution-ready plans.

Professor, Partner

Artificial Intelligence Internationally recognised authority on AI with three decades across academia, entrepreneurship and corporate transformation.

Senior Partner

Turnaround and transformation CFO with 30+ years’ experience across technology and telecoms. Specialist in carve-outs, start-ups, and value creation, delivering operational improvement, cash flow optimisation, and execution-ready financial strategy.

Senior Partner , Cyber Security

Cybersecurity entrepreneur, Multi-Patent holder and Forbes-recognised innovator specialising in Cyber security service delivery, and Cyber security compliance and Governanance. Founder of Uncloak, and fractional Information Security Officer — building scalable security programmes and AI-powered platforms that deliver measurable outcomes for organisations across the UK and beyond.

Partner & Carve Out Practice Lead

Enterprise architecture and security transformation leader specialising in carve-outs, M&A integration, technology consolidation, and value creation. Delivers execution-ready strategies that rationalise complex estates, uplift cyber resilience, and enable scalable growth across FTSE 100 and global enterprise environments.

Fractional CISO & Cyber Consultant

Andrew Fruish is a cyber security and technology risk specialist focused on private equity, M&A, carve-outs, and post-deal value protection. He helps investors and portfolio companies identify material cyber risk, shape remediation priorities, and deliver execution-ready plans that reduce downside, support separation, and strengthen exit readiness.

AI & Value Creation Analyst

Passionate for driving disruption and value creation through technology. He combines a strong technical foundation with experience advising C-suite executives at technology startups, helping businesses scale and innovate.

Advisors

Founder, Investor & Senior Advisor

AI and data expert helping private equity unlock smarter deals and value creation. Built advanced intelligence platforms at Vitruvian and real-time market data systems at BGC Partners.

Professor of Biomedical Sciences & Senior Advisor

Justin is a Professor at ARU Cambridge and Visiting Professor at Imperial College London, with over 700 publications in leading journals including The Lancet and NEJM. His work focuses on cancer therapies, gene regulation, and drug development, and he played a key role in research leading to the FDA approval of baricitinib for COVID-19. He also serves as SVP at Graviton and has experience in investment.